Citi Appointed Depositary Bank for LianBio’s Sponsored ADR Program
Citibank has been appointed as the depositary bank for LianBio's American Depositary Receipt (ADR) program, coinciding with an IPO of approximately $325 million. Each ADS is priced at $16.00 and represents one ordinary share, listed on Nasdaq under the ticker symbol LIAN. Dirk Jones, Global Head of Issuer Services at Citi, emphasized Citi's commitment to providing high-quality ADR services for LianBio, showcasing Citi's extensive cross-border capabilities. This collaboration aims to enhance capital market access for global investors.
- Appointment of Citibank as depositary bank signifies LianBio's growth potential.
- Successful IPO of approximately $325 million indicates strong market interest.
- None.
The
“Citi is committed to providing
Citi is a leading provider of depositary receipt services. With depositary receipt programs in 67 markets, spanning equity and fixed-income products, Citi leverages its global network to provide cross-border capital market access to issuers, intermediaries and investors.
For more information about Citi’s Depositary Receipt Services, please visit www.citi.com/dr.
Citi
Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.
Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi
View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005280/en/
Media :
+1 (212) 816-9267
nina.das@citi.com
Source: Citi
FAQ
What recent announcement did LianBio make regarding its ADR program?
How much was LianBio's initial public offering?
What is the price of LianBio's American Depositary Shares (ADSs)?